Global Lung Cancer Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 80674
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Lung Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Lung Cancer size is estimated to be USD 26590 million in 2026 from USD 20010 million in 2020, with a change XX% between 2020 and 2021. The global Lung Cancer market size is expected to grow at a CAGR of 7.4% for the next five years.

Market segmentation

Lung Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Surgery

Chemotherapy

Radiotherapy

Photodynamic Therapy

Laser Therapy

Market segment by Application, can be divided into

Hospital & Clinics

Cancer Research Centers

Others

Market segment by players, this report covers

Roche

Novartis

Pfizer

Merck

Bristol-Myers Squibb

Eli Lilly And Company

Sanof

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Lung Cancer product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Lung Cancer, with revenue, gross margin and global market share of Lung Cancer from 2019 to 2021.

Chapter 3, the Lung Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Lung Cancer market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Lung Cancer research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Lung Cancer

1.2 Classification of Lung Cancer by Type

1.2.1 Overview: Global Lung Cancer Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Lung Cancer Revenue Market Share by Type in 2020

1.2.3 Surgery

1.2.4 Chemotherapy

1.2.5 Radiotherapy

1.2.6 Photodynamic Therapy

1.2.7 Laser Therapy

1.3 Global Lung Cancer Market by Application

1.3.1 Overview: Global Lung Cancer Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital & Clinics

1.3.3 Cancer Research Centers

1.3.4 Others

1.4 Global Lung Cancer Market Size & Forecast

1.5 Global Lung Cancer Market Size and Forecast by Region

1.5.1 Global Lung Cancer Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Lung Cancer Market Size by Region, (2016-2021)

1.5.3 North America Lung Cancer Market Size and Prospect (2016-2026)

1.5.4 Europe Lung Cancer Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Lung Cancer Market Size and Prospect (2016-2026)

1.5.6 South America Lung Cancer Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Lung Cancer Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Lung Cancer Market Drivers

1.6.2 Lung Cancer Market Restraints

1.6.3 Lung Cancer Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Lung Cancer Product and Solutions

2.1.4 Roche Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Roche Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Lung Cancer Product and Solutions

2.2.4 Novartis Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Lung Cancer Product and Solutions

2.3.4 Pfizer Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Lung Cancer Product and Solutions

2.4.4 Merck Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Bristol-Myers Squibb

2.5.1 Bristol-Myers Squibb Details

2.5.2 Bristol-Myers Squibb Major Business

2.5.3 Bristol-Myers Squibb Lung Cancer Product and Solutions

2.5.4 Bristol-Myers Squibb Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.6 Eli Lilly And Company

2.6.1 Eli Lilly And Company Details

2.6.2 Eli Lilly And Company Major Business

2.6.3 Eli Lilly And Company Lung Cancer Product and Solutions

2.6.4 Eli Lilly And Company Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Eli Lilly And Company Recent Developments and Future Plans

2.7 Sanof

2.7.1 Sanof Details

2.7.2 Sanof Major Business

2.7.3 Sanof Lung Cancer Product and Solutions

2.7.4 Sanof Lung Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Sanof Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Lung Cancer Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Lung Cancer Players Market Share

3.2.2 Top 10 Lung Cancer Players Market Share

3.2.3 Market Competition Trend

3.3 Lung Cancer Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Lung Cancer Revenue and Market Share by Type (2016-2021)

4.2 Global Lung Cancer Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Lung Cancer Revenue Market Share by Application (2016-2021)

5.2 Lung Cancer Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Lung Cancer Revenue by Type (2016-2026)

6.2 North America Lung Cancer Revenue by Application (2016-2026)

6.3 North America Lung Cancer Market Size by Country

6.3.1 North America Lung Cancer Revenue by Country (2016-2026)

6.3.2 United States Lung Cancer Market Size and Forecast (2016-2026)

6.3.3 Canada Lung Cancer Market Size and Forecast (2016-2026)

6.3.4 Mexico Lung Cancer Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Lung Cancer Revenue by Type (2016-2026)

7.2 Europe Lung Cancer Revenue by Application (2016-2026)

7.3 Europe Lung Cancer Market Size by Country

7.3.1 Europe Lung Cancer Revenue by Country (2016-2026)

7.3.2 Germany Lung Cancer Market Size and Forecast (2016-2026)

7.3.3 France Lung Cancer Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Lung Cancer Market Size and Forecast (2016-2026)

7.3.5 Russia Lung Cancer Market Size and Forecast (2016-2026)

7.3.6 Italy Lung Cancer Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Lung Cancer Revenue by Type (2016-2026)

8.2 Asia-Pacific Lung Cancer Revenue by Application (2016-2026)

8.3 Asia-Pacific Lung Cancer Market Size by Region

8.3.1 Asia-Pacific Lung Cancer Revenue by Region (2016-2026)

8.3.2 China Lung Cancer Market Size and Forecast (2016-2026)

8.3.3 Japan Lung Cancer Market Size and Forecast (2016-2026)

8.3.4 South Korea Lung Cancer Market Size and Forecast (2016-2026)

8.3.5 India Lung Cancer Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Lung Cancer Market Size and Forecast (2016-2026)

8.3.7 Australia Lung Cancer Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Lung Cancer Revenue by Type (2016-2026)

9.2 South America Lung Cancer Revenue by Application (2016-2026)

9.3 South America Lung Cancer Market Size by Country

9.3.1 South America Lung Cancer Revenue by Country (2016-2026)

9.3.2 Brazil Lung Cancer Market Size and Forecast (2016-2026)

9.3.3 Argentina Lung Cancer Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Lung Cancer Revenue by Type (2016-2026)

10.2 Middle East & Africa Lung Cancer Revenue by Application (2016-2026)

10.3 Middle East & Africa Lung Cancer Market Size by Country

10.3.1 Middle East & Africa Lung Cancer Revenue by Country (2016-2026)

10.3.2 Turkey Lung Cancer Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Lung Cancer Market Size and Forecast (2016-2026)

10.3.4 UAE Lung Cancer Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Lung Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Lung Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Lung Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Lung Cancer Revenue (USD Million) by Region (2016-2021)

Table 5. Global Lung Cancer Revenue Market Share by Region (2021-2026)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Lung Cancer Product and Solutions

Table 9. Roche Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Lung Cancer Product and Solutions

Table 13. Novartis Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Lung Cancer Product and Solutions

Table 17. Pfizer Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Lung Cancer Product and Solutions

Table 21. Merck Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 23. Bristol-Myers Squibb Major Business

Table 24. Bristol-Myers Squibb Lung Cancer Product and Solutions

Table 25. Bristol-Myers Squibb Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Eli Lilly And Company Corporate Information, Head Office, and Major Competitors

Table 27. Eli Lilly And Company Major Business

Table 28. Eli Lilly And Company Lung Cancer Product and Solutions

Table 29. Eli Lilly And Company Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Sanof Corporate Information, Head Office, and Major Competitors

Table 31. Sanof Major Business

Table 32. Sanof Lung Cancer Product and Solutions

Table 33. Sanof Lung Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Global Lung Cancer Revenue (USD Million) by Players (2019-2021)

Table 35. Global Lung Cancer Revenue Share by Players (2019-2021)

Table 36. Breakdown of Lung Cancer by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. Lung Cancer Players Head Office, Products and Services Provided

Table 38. Lung Cancer Mergers & Acquisitions in the Past Five Years

Table 39. Lung Cancer New Entrants and Expansion Plans

Table 40. Global Lung Cancer Revenue (USD Million) by Type (2016-2021)

Table 41. Global Lung Cancer Revenue Share by Type (2016-2021)

Table 42. Global Lung Cancer Revenue Forecast by Type (2021-2026)

Table 43. Global Lung Cancer Revenue by Application (2016-2021)

Table 44. Global Lung Cancer Revenue Forecast by Application (2021-2026)

Table 45. North America Lung Cancer Revenue by Type (2016-2021) & (USD Million)

Table 46. North America Lung Cancer Revenue by Type (2021-2026) & (USD Million)

Table 47. North America Lung Cancer Revenue by Application (2016-2021) & (USD Million)

Table 48. North America Lung Cancer Revenue by Application (2021-2026) & (USD Million)

Table 49. North America Lung Cancer Revenue by Country (2016-2021) & (USD Million)

Table 50. North America Lung Cancer Revenue by Country (2021-2026) & (USD Million)

Table 51. Europe Lung Cancer Revenue by Type (2016-2021) & (USD Million)

Table 52. Europe Lung Cancer Revenue by Type (2021-2026) & (USD Million)

Table 53. Europe Lung Cancer Revenue by Application (2016-2021) & (USD Million)

Table 54. Europe Lung Cancer Revenue by Application (2021-2026) & (USD Million)

Table 55. Europe Lung Cancer Revenue by Country (2016-2021) & (USD Million)

Table 56. Europe Lung Cancer Revenue by Country (2021-2026) & (USD Million)

Table 57. Asia-Pacific Lung Cancer Revenue by Type (2016-2021) & (USD Million)

Table 58. Asia-Pacific Lung Cancer Revenue by Type (2021-2026) & (USD Million)

Table 59. Asia-Pacific Lung Cancer Revenue by Application (2016-2021) & (USD Million)

Table 60. Asia-Pacific Lung Cancer Revenue by Application (2021-2026) & (USD Million)

Table 61. Asia-Pacific Lung Cancer Revenue by Region (2016-2021) & (USD Million)

Table 62. Asia-Pacific Lung Cancer Revenue by Region (2021-2026) & (USD Million)

Table 63. South America Lung Cancer Revenue by Type (2016-2021) & (USD Million)

Table 64. South America Lung Cancer Revenue by Type (2021-2026) & (USD Million)

Table 65. South America Lung Cancer Revenue by Application (2016-2021) & (USD Million)

Table 66. South America Lung Cancer Revenue by Application (2021-2026) & (USD Million)

Table 67. South America Lung Cancer Revenue by Country (2016-2021) & (USD Million)

Table 68. South America Lung Cancer Revenue by Country (2021-2026) & (USD Million)

Table 69. Middle East & Africa Lung Cancer Revenue by Type (2016-2021) & (USD Million)

Table 70. Middle East & Africa Lung Cancer Revenue by Type (2021-2026) & (USD Million)

Table 71. Middle East & Africa Lung Cancer Revenue by Application (2016-2021) & (USD Million)

Table 72. Middle East & Africa Lung Cancer Revenue by Application (2021-2026) & (USD Million)

Table 73. Middle East & Africa Lung Cancer Revenue by Country (2016-2021) & (USD Million)

Table 74. Middle East & Africa Lung Cancer Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Lung Cancer Picture

Figure 2. Global Lung Cancer Revenue Market Share by Type in 2020

Figure 3. Surgery

Figure 4. Chemotherapy

Figure 5. Radiotherapy

Figure 6. Photodynamic Therapy

Figure 7. Laser Therapy

Figure 8. Lung Cancer Revenue Market Share by Application in 2020

Figure 9. Hospital & Clinics Picture

Figure 10. Cancer Research Centers Picture

Figure 11. Others Picture

Figure 12. Global Lung Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Lung Cancer Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Lung Cancer Revenue Market Share by Region (2016-2026)

Figure 15. Global Lung Cancer Revenue Market Share by Region in 2020

Figure 16. North America Lung Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Lung Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Lung Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Lung Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Lung Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Lung Cancer Market Drivers

Figure 22. Lung Cancer Market Restraints

Figure 23. Lung Cancer Market Trends

Figure 24. Roche Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. Pfizer Recent Developments and Future Plans

Figure 27. Merck Recent Developments and Future Plans

Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 29. Eli Lilly And Company Recent Developments and Future Plans

Figure 30. Sanof Recent Developments and Future Plans

Figure 31. Global Lung Cancer Revenue Share by Players in 2020

Figure 32. Lung Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 33. Global Top 3 Players Lung Cancer Revenue Market Share in 2020

Figure 34. Global Top 10 Players Lung Cancer Revenue Market Share in 2020

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 36. Global Lung Cancer Revenue Share by Type in 2020

Figure 37. Global Lung Cancer Market Share Forecast by Type (2021-2026)

Figure 38. Global Lung Cancer Revenue Share by Application in 2020

Figure 39. Global Lung Cancer Market Share Forecast by Application (2021-2026)

Figure 40. North America Lung Cancer Sales Market Share by Type (2016-2026)

Figure 41. North America Lung Cancer Sales Market Share by Application (2016-2026)

Figure 42. North America Lung Cancer Revenue Market Share by Country (2016-2026)

Figure 43. United States Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Canada Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Mexico Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Europe Lung Cancer Sales Market Share by Type (2016-2026)

Figure 47. Europe Lung Cancer Sales Market Share by Application (2016-2026)

Figure 48. Europe Lung Cancer Revenue Market Share by Country (2016-2026)

Figure 49. Germany Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Lung Cancer Sales Market Share by Type (2016-2026)

Figure 55. Asia-Pacific Lung Cancer Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Lung Cancer Revenue Market Share by Region (2016-2026)

Figure 57. China Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. South Korea Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Lung Cancer Sales Market Share by Type (2016-2026)

Figure 64. South America Lung Cancer Sales Market Share by Application (2016-2026)

Figure 65. South America Lung Cancer Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East and Africa Lung Cancer Sales Market Share by Type (2016-2026)

Figure 69. Middle East and Africa Lung Cancer Sales Market Share by Application (2016-2026)

Figure 70. Middle East and Africa Lung Cancer Revenue Market Share by Country (2016-2026)

Figure 71. Turkey Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Saudi Arabia Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. UAE Lung Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz